HYALGAN

Trade name:

HYALGAN 20 mg / 2 ml pre-filled syringe N1

Cod ATC:

M09AX01

Active substance:

Dosage:

Manufacturer

Fidia Farmaceutici S.p.A. Via Ponte della Fabbrica 3/A – 35031 Abano Terme (PD) – Italy

Therapeutic indications:

  • Treatment of people with osteoarthritis I to IV stages
  • Restoration the normal function of the affected joint after surgery.

Description:

HYALGAN is the only medicine based on natural sodium hyaluronate with a double effect of viscoinduction and viscosupplementation. Intra-articular administration in 3-5 weekly doses, decreases joint pain and stiffness, as well as improves joint function for up to 12 weeks. It has a regenerating effect on articular cartilage, while reducing joint inflammation.

Pharmacovigilance

Information about drug safety

Pharmacovigilance is the science and activities related to the detection, evaluation, understanding and prevention of adverse effects or any other problem related to medicines.

Report reaction

More medications and nutritional supplements

All products